Cite
HARVARD Citation
Rao, V. et al. (n.d.). FRI0137 Risk factors for major adverse cardiovascular (CV) events (MACE) in rheumatoid arthritis (RA) patients treated with tocilizumab (TCZ). Annals of the rheumatic diseases. pp. 356-357. [Online].